Table 2 Areas where machine learning could be leveraged for improving the accuracy of estimations or projections and potential data sources identified through the review of traditional approaches.

From: Leveraging artificial intelligence for pandemic preparedness and response: a scoping review to identify key use cases

Use cases

Data sources

Infectious disease dynamics: R0, reproduction number1; peak time, intensity, and duration2; proportion of asymptomatic infections3; transmission rate4; household transmission5; spatiotemporal dynamics with GIS6; population immunity7

Published literature: seroconversion40; vaccine effectiveness42; estimates from other diseases (e.g., SARS)46

Publicly available data: COVID-19 global cases from the Center for Systems Science and Engineering at Johns Hopkins University47; Worldometer COVID-19 pandemic updates48

Health outcomes: infections8; severe cases9; susceptibility10; deaths11; latency and infectious period12; undetected cases13; infections among healthcare workers14; infections among incarcerated populations15; infections among homeless populations16

Government data: government reported case data1; census data49; World Health Organization case reports and data on respiratory risk factors50; Ministry of Civil Aviation (i.e., airline passenger data)6; airport transportation data51; Armed Forces health surveillance data52; board of education school data (e.g., absentee reports that document H1N1)53; hospital/outpatient sentinel surveillance21

Impact on healthcare systems and demand for: inpatient beds17; intensive care unit beds18; N95 respirators and surgical masks19; ventilators18; medical supplies20; staffing21

Effects of NPIs: social distancing22; self-isolation/quarantining2; workplace closures23; contact tracing24; wearing masks by general population25; handwashing26; optimal assay test pooling strategies for efficient testing27; frequency of routine testing for COVID-19 in high-risk environments to reduce workplace outbreaks28; mass testing/using drones to deliver tests29; periodic testing of health workforce30; impact of NPIs in residential care facilities31; closing borders32; effectiveness of airport thermal screening33; restrictions to sea, land and air travel34; school closures35; control measures for children if schools open (e.g., better ventilation, mask wearing)36; public risk communication37; media/news reports37; impact of available information on behavior and vaccination uptake38; ventilation of indoor spaces39

Mobile phone mobility data54

Daily news reports37

Purchasing information55

Google mobility reports using five different categories: retail and recreation, grocery and pharmacy, transit stations, workplace, and residential56

Google query and news data57

Google Flu Trends data58

Apple Maps COVID-19 mobility trends59

Publicly available data on infection rates from cruise companies60,61

Impact of lifting NPI-related restrictions40

Effects of pharmaceutical interventions: use of antiviral medications41; vaccination strategies42; disease spread given vaccination availability constraints43; transmission risk at immunization clinics44

National Oceanic and Atmospheric Administration: temperature, humidity, wind speed62,63

Home television watching (i.e., proxy for time spent at home)64

Humanitarian assistance such as food distribution planning45

  1. 1-64Provided in supplementary references.
  2. COVID-19 coronavirus disease 2019, GIS geographic information system, H1N1 pandemic influenza A subtype H1N1, NPI non-pharmaceutical intervention, SARS severe acute respiratory syndrome.